Bio-Techne (TECH) FCF Margin (2009 - 2026)
Bio-Techne's quarterly FCF Margin came in at 24.91% in Q1 2026, up 1511.0% year-on-year from 1.55% in Q1 2025, and down 3.64% quarter-over-quarter from 25.85% in Q4 2025.
Bio-Techne has reported FCF Margin for 18 years, with the latest figure at 24.91% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 1511.0% year-over-year to 24.91%; the trailing twelve-month figure through Mar 2026 stood at 22.27% (up 400.0% YoY), and the FY2025 full-year result was 21.03%, up 66.0% from the prior year.
- FCF Margin for Q1 2026 stood at 24.91%, down from 25.85% in the prior quarter.
- The five-year high for FCF Margin was 2326.25% in Q3 2022, with the low at 7.75% in Q3 2025.
- Average FCF Margin over 5 years is 156.49%, with a median of 21.46% recorded in 2022.
- Year-over-year, FCF Margin soared 230981 bps in 2022 and tumbled 230972 bps in 2023.
- Tracing TECH's FCF Margin over 5 years: stood at 21.46% in 2022, then rose by 17 bps to 25.04% in 2023, then grew by 4 bps to 26.1% in 2024, then dropped by 1 bps to 25.85% in 2025, then fell by 4 bps to 24.91% in 2026.
- The last three FCF Margin figures came in at 24.91% (Q1 2026), 25.85% (Q4 2025), and 7.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.17% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 24.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.91% |
| Dec 31, 2025 | 25.85% |
| Sep 30, 2025 | 7.75% |
| Jun 30, 2025 | 29.44% |
| Mar 31, 2025 | 9.80% |
| Dec 31, 2024 | 26.10% |
| Sep 30, 2024 | 18.90% |
| Jun 30, 2024 | 18.79% |
| Mar 31, 2024 | 21.27% |
| Dec 31, 2023 | 25.04% |
| Sep 30, 2023 | 16.53% |
| Jun 30, 2023 | 24.08% |
| Mar 31, 2023 | 13.19% |
| Dec 31, 2022 | 21.46% |
| Sep 30, 2022 | 2,326.25% |
| Jun 30, 2022 | 30.93% |
| Mar 31, 2022 | 19.98% |
| Dec 31, 2021 | 33.73% |
| Sep 30, 2021 | 16.44% |
| Jun 30, 2021 | 42.74% |
| Mar 31, 2021 | 26.39% |
| Dec 31, 2020 | 34.70% |
| Sep 30, 2020 | 26.97% |
| Jun 30, 2020 | 15.59% |
| Mar 31, 2020 | 20.64% |
| Dec 31, 2019 | 30.20% |
| Sep 30, 2019 | 16.38% |
| Jun 30, 2019 | 23.09% |
| Mar 31, 2019 | 18.79% |
| Dec 31, 2018 | 24.04% |
| Sep 30, 2018 | 21.63% |
| Jun 30, 2018 | 32.74% |
| Mar 31, 2018 | 11.06% |
| Dec 31, 2017 | 21.31% |
| Sep 30, 2017 | 27.26% |
| Jun 30, 2017 | 28.73% |
| Mar 31, 2017 | 14.58% |
| Dec 31, 2016 | 29.42% |
| Sep 30, 2016 | 18.43% |
| Jun 30, 2016 | 24.93% |
| Mar 31, 2016 | 26.19% |
| Dec 31, 2015 | 27.83% |
| Sep 30, 2015 | 22.88% |
| Jun 30, 2015 | 25.67% |
| Mar 31, 2015 | 22.65% |
| Dec 31, 2014 | 29.11% |
| Sep 30, 2014 | 28.41% |
| Jun 30, 2014 | 38.71% |
| Mar 31, 2014 | 32.10% |
| Dec 31, 2013 | 32.94% |
| Sep 30, 2013 | 33.59% |
| Jun 30, 2013 | 31.00% |
| Mar 31, 2013 | 32.91% |
| Dec 31, 2012 | 30.72% |
| Sep 30, 2012 | 35.65% |
| Jun 30, 2012 | 46.11% |
| Mar 31, 2012 | 39.32% |
| Dec 31, 2011 | 24.43% |
| Sep 30, 2011 | 42.96% |
| Jun 30, 2011 | 42.80% |
| Mar 31, 2011 | 41.69% |
| Dec 31, 2010 | 42.42% |
| Sep 30, 2010 | 43.64% |
| Jun 30, 2010 | 45.95% |
| Mar 31, 2010 | 31.09% |
| Dec 31, 2009 | 40.66% |
| Sep 30, 2009 | 41.28% |